These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30248592)

  • 1. Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Blennow K; Rosengren L; Eriksson B; Gudmundsdottir T; Jansson Y; Johnels B; Renck A; Bergquist F
    Clin Neurol Neurosurg; 2018 Nov; 174():174-179. PubMed ID: 30248592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.
    Constantinescu R; Holmberg B; Rosengren L; Corneliusson O; Johnels B; Zetterberg H
    Acta Neurol Scand; 2011 Sep; 124(3):206-10. PubMed ID: 21039366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity levels in people with Parkinson's disease treated by subthalamic nucleus deep brain stimulation.
    Danoudis M; Iansek R
    Disabil Rehabil; 2023 Sep; 45(18):2890-2895. PubMed ID: 36124542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 8-Year Follow-up on the Effect of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease.
    Jung YJ; Kim HJ; Jeon BS; Park H; Lee WW; Paek SH
    JAMA Neurol; 2015 May; 72(5):504-10. PubMed ID: 25799451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of precise electrode positioning in STN DBS on three-year outcomes.
    Paek SH; Yun JY; Song SW; Kim IK; Hwang JH; Kim JW; Kim HJ; Kim HJ; Kim YE; Lim YH; Kim MR; Huh JH; Lee KM; Park SK; Kim C; Kim DG; Jeon BS
    J Neurol Sci; 2013 Apr; 327(1-2):25-31. PubMed ID: 23465484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?
    Asha MJ; Kausar J; Krovvidi H; Shirley C; White A; Chelvarajah R; Hodson JA; Pall H; Mitchell RD
    Acta Neurochir (Wien); 2016 Feb; 158(2):387-93. PubMed ID: 26602236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus.
    Volonté MA; Clarizio G; Galantucci S; Scamarcia PG; Cardamone R; Barzaghi LR; Falautano M; Mortini P; Comi G; Filippi M
    J Neurol; 2021 Aug; 268(8):2821-2830. PubMed ID: 33598766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for postoperative urinary retention after deep brain stimulation surgery: the role of the subthalamic nucleus.
    Porche K; Peart R; Silva V; Mampre D; Chandra V; Zakare-Fagbamila R; Foote K; Hilliard JD; Robicsek S
    J Neurosurg; 2024 Jul; 141(1):221-229. PubMed ID: 38306648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease.
    Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z
    J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.
    Georgiev D; Dirnberger G; Wilkinson L; Limousin P; Jahanshahi M
    Exp Brain Res; 2016 Apr; 234(4):1133-43. PubMed ID: 26758720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.